(Reuters) - Eli Lilly's drug Mounjaro has won the backing of Britain's drug cost-effectiveness watchdog as a diabetes treatment, Bloomberg News ...
STORY CONTINUES BELOW THESE SALTWIRE VIDEOS - Eli Lilly's drug Mounjaro has won the backing of Britain's drug cost-effectiveness watchdog as a diabetes treatment, Bloomberg News reported on Thursday.
Mounjaro is expected to become a blockbuster treatment if it is also approved to treat obesity and a U.S. decision on its use for weight loss is expected later this year. Bloomberg News quoted Helen Knight, director of medicines evaluation at the National Institute for Health and Care Excellence as saying that Mounjaro has the potential to"provide an effective and good value treatment option" for people with type 2 diabetes that isn't well controlled by other drugs.Earlier in July, NICE did not recommend Mounjaro, also known as tirzepatide, saying more evidence was needed before it could be used by the National Health Service.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Lilly's diabetes drug gains backing of UK watchdog -Bloomberg News(Reuters) - Eli Lilly's drug Mounjaro has won the backing of Britain's drug cost-effectiveness watchdog as a diabetes treatment, Bloomberg News ...
Lire la suite »
Weinstein group revises Sculptor bid after board's concerns -Bloomberg News(Reuters) - Wall Street investor Boaz Weinstein and his group of bidders have revised their offer to buy hedge fund firm Sculptor Capital Management, ...
Lire la suite »
G20 agrees membership for African Union on par with EU -Bloomberg News(Reuters) - The G20 grouping of nations has agreed to grant permanent membership to the African Union, Bloomberg News said on Thursday, citing people ...
Lire la suite »
G20 agrees membership for African Union on par with EU -Bloomberg News(Reuters) - The G20 grouping of nations has agreed to grant permanent membership to the African Union, Bloomberg News said on Thursday, citing people ...
Lire la suite »
News Corp in negotiations with AI companies over content usageBy Helen Coster and Zaheer Kachwala (Reuters) - News Corp is engaged in
Lire la suite »
Diabetes Patients in UK to Get Eli Lilly Drug, Rivaling OzempicEli Lilly & Co.’s Mounjaro, a diabetes drug that’s also nearing approval for weight loss, is set to reach UK patients after winning the backing of England’s influential health-cost regulator.
Lire la suite »